Lanfear Dennis M
SEC CIK 1420822 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| CHRS | Coherus Oncology, Inc. | Pres, CEO, Dir | 1.05M | — | $450.7K | 13 | 2021-11-17 | 2026-01-23 |
Most active insiders at CHRS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Ryan Michael Lee | Dir | — | — |
| 2 | McMichael Bryan J | CFO | — | — |
| 3 | O'Donnell-Tormey Jill | Dir | — | — |
| 4 | Newton Charles W. | Dir | — | — |
| 5 | Newcomer Lee Nisley | Dir | — | — |
| 6 | Satvat Ali J. | Dir | — | — |
| 7 | Karachun Rita A | Dir | — | — |
| 8 | Wahlstrom Mats | Dir | — | — |
| 9 | Lanfear Dennis M | Pres, CEO, Dir | — | — |
Transactions 13
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-01-26 | 2026-01-23 | CHRS | Coherus Oncology, Inc. | Lanfear Dennis M | Pres, CEO, Dir | A - Grant | $0.00 | +375.0K | 1.05M | +56% | $0 |
| 2026-01-22 | 2026-01-20 | CHRS | Coherus Oncology, Inc. | Lanfear Dennis M | Pres, CEO, Dir | F - Tax | $1.55 | -11.8K | 673.2K | -2% | -$18.4K | |
| 2025-01-22 | 2025-01-20 | CHRS | Coherus Oncology, Inc. | Lanfear Dennis M | Pres, CEO, Dir | F - Tax | $1.39 | -11.8K | 685.1K | -2% | -$16.4K | |
| 2025-01-07 | 2025-01-04 | CHRS | Coherus Oncology, Inc. | Lanfear Dennis M | Pres, CEO, Dir | F - Tax | $1.66 | -11.8K | 696.9K | -2% | -$19.6K | |
| 2024-01-23 | 2024-01-20 | CHRS | Coherus Oncology, Inc. | Lanfear Dennis M | Pres, CEO, Dir | F - Tax | $2.44 | -11.2K | 708.7K | -2% | -$27.4K | |
| D | 2024-01-08 | 2024-01-04 | CHRS | Coherus Oncology, Inc. | Lanfear Dennis M | Pres, CEO, Dir | F - Tax | $2.92 | -11.8K | 719.9K | -2% | -$34.4K |
| DM | 2023-11-24 | 2023-11-22 | CHRS | Coherus Oncology, Inc. | Lanfear Dennis M | Pres, CEO, Dir | M - OptEx | $1.42 | +299.9K | 954.8K | +46% | +$425.9K |
| D | 2023-11-24 | 2023-11-22 | CHRS | Coherus Oncology, Inc. | Lanfear Dennis M | Pres, CEO, Dir | S - Sale+OE | $2.02 | -223.1K | 731.7K | -23% | -$450.7K |
| 2023-01-24 | 2023-01-20 | CHRS | Coherus Oncology, Inc. | Lanfear Dennis M | Pres, CEO, Dir | A - Grant | $0.00 | +86.2K | 654.9K | +15% | $0 | |
| D | 2023-01-06 | 2023-01-04 | CHRS | Coherus Oncology, Inc. | Lanfear Dennis M | Pres, CEO, Dir | F - Tax | $9.87 | -10.9K | 568.6K | -2% | -$107.6K |
| I | 2023-01-04 | 2022-12-30 | CHRS | Coherus Oncology, Inc. | Lanfear Dennis M | Pres, CEO, Dir | G - Gift | $0.00 | -4,000 | 432.7K | -0.9% | $0 |
| D | 2022-01-06 | 2022-01-04 | CHRS | Coherus Oncology, Inc. | Lanfear Dennis M | Pres, CEO, Dir | A - Grant | $0.00 | +86.2K | 579.5K | +17% | $0 |
| I | 2021-11-23 | 2021-11-17 | CHRS | Coherus Oncology, Inc. | Lanfear Dennis M | Pres, CEO, Dir | G - Gift | $0.00 | -10.0K | 436.7K | -2% | $0 |
Purchase Sale Sale after option exercise All abbreviations